Hana Financial
Korea anti-aging polymer maker gets $22m
Dexlevo, a Korean biotech company specializing in anti-aging dermal fillers, has raised KRW26 billion ($22 million) in pre-IPO funding led by local GPs Magna Investment and Smilegate Investment.
Deal focus: Biotech gets more cerebral
As opportunity appears to plateau in the most popular biotech segments, brain health could come to the fore. Neurology specialist Cerecin is tracking greater interest amid industry traction in the lab
Korea GPs invest $40m in Singapore biotech player
A group of Korean private equity investors has committed $40 million in funding to Cerecin, a Singapore-based biotech developer focused on neurotherapeutics.
Hana invests $85m in Asia renewables platform
Hana Financial has invested KRW100 billion ($85 million) in a portfolio of Korean waste to energy (WTE) projects being developed by Equis Development.
Goldman Sachs exits Hana in $331m sell down
Goldman Sachs has exited the remainder of its stake in South Korea's Hana Financial Group through a public market sell down worth $331 million.
Lone Star wins approval for KEB sale
Embattled buyout firm Lone Star has finally gained approval from the necessary parties for the sale of its 51% stake in Korea Exchange Bank to Hana Financial Group.
Another KEB backer looks to divest stake
The Export-Import Bank of Korea (KEXIM) is looking to sell its 6.25% stake in Korea Exchange Bank, coming as embattled buyout fund Lone Star is set to offload its 51% majority stake in the company to Hana Financial Group.
Hana's board approves $3.5b KEB purchase
Hana Financial Group has approved a plan to acquire the 51% stake in Korea Exchange Bank (KEB) held by US buyout fund Lone Star for KRW3.92 trillion ($3.5 billion). Pending regulatory approval, the transaction could be completed by the year’s end, signaling...
Korean regulators to investigate KEB
South Korean regulators have launched a probe into the inside operations of Korea Exchange Bank (KEB) to ensure that the lender complied with court orders to fire members of its board related to embattled owner Lone Star.
Hana denies asking Lone Start to cut KEB sale price
Hana Financial Group has denied reports that it had asked Lone Star to cut the $4.16 billion acquisition price for Korea Exchange Bank (KEB) by one fifth. It was claimed that the US private equity firm responded by threatening to walk away from the deal...
Lone Star has six months to reduce KEB stake
Lone Star may have no more than six months to reduce its stake in Korea Exchange Bank (KEB) to 10% or lower after Korea’s Financial Services Commission said Monday that it had begun the process of ordering a divestment. The move comes in response to...
Private equity and the state
The state, particularly in Asian countries, has always played a big role in the private equity industry. While almost all growing regional economies have helped nurture PE through sovereign wealth funds – fueled by foreign exchange and other cash reserves...
KEXIM to sell KEB stake as part of Lone Star transaction
Export-Import Bank of Korea (KEXIM) will sell a 6.25% stake in Korea Exchange Bank to Hana Financial Group as a “tag along” to Hana’s purchase of Lone Star’s holding in the bank, according to Yonhap, a South Korean news agency. The tag along right...
Lone Star, Hana agree on cut-price deal for KEB
Lone Star will sell its stake in Korea Exchange Bank (KEB) to Hana Financial Group for just over KRW4.4 trillion ($4.16 billion), after both sides agreed to cut the price tag by KRW283 billion ($266 million). The price for the 51% stake in KEB has been...
Korean financial plays are not for foreigners
The Woori and Mirae Asset Life Insurance deals are cause for hope, but foreign PE may still find life difficult
Temasek reduces holdings in Bank of China, China Construction Bank
Temasek Holdings, Singapore’s second-largest sovereign wealth fund, has reduced its holdings in Bank of China and China Construction Bank in order to scale back on its financial sector exposure, raising around $3.6 billion in the process.